MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Recruiting Observational Study
Gaucher Disease, Type 3
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
5 (estimated)
Sponsor
University of Minnesota · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Recent studies have has shown that magnetic resonance spectroscopy (MRS) can provide validated neuronal markers in patients with Type 1 GD (GD1) who are on stable therapy. However, alterations in neurometabolites in adult patients with GD3, who have established neurological involvement, are not well understood. The goal of this study is to characterize neurometabolite profiles in adult patients wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All participants must be 18 years or older. * All enrollees must understand and cooperate with requirements of the study in the opinion of the investigators and must be able to provide written informed consent. * Individuals with GD3 who are medically stable for participation …
Contacts

Reena Kartha, PhD

612-626-2436

rvkartha@umn.edu

CONTACT

Raghu Sharma, PhD

rsharma@umn.edu

CONTACT